AstraZeneca, decided to withdrawal from the KDPU

It is the third after Janssen and Novonordisk, and MSD Korea is also about to leave.

AstraZeneca Korea decided to withdraw from the KDPU(Korea Democratic Pharmaceutical Union).

 

The branches of the KDPU have been reduced to 18, including 17 multinationals and 1 domestic.

 

According to the pharmaceutical industry on the 6th, the Branch of AstraZeneca Korea under the KDPU has voted for members whether or not to withdraw from the end of this January.

 

As a result of the voting, More members were in favor of the withdrawal.

 

After the withdrawal process, the union of AstraZeneka Korea will conduct collective bargaining with the company as an industrial union.

 

AstraZeneca Korea's withdrawal from the KDPU is the third after Janssen Korea and Novonordisk.

 

Prior to AstraZeneca Korea, the majority of members withdrew from the MSD Branch of Korea, but it did not lead to a complete withdrawal yet.

 

At the end of last year, MSD Korea withdrew 300 members out of 380 members of the KDPU.

 

There are currently two unions in the MSD Korea.

 

Reasons for withdrawal include unequal voting rights and an increase in union costs.

 

The KDPU are currently entitled to one vote per company regardless of the number of members.

 

As a result, large companies continue to complain.

 

It is reported that the union's executive department recently decided to raise union costs.

 

In the case of large companies, the right to vote is limited and union costs have increased, which is a double burden.

 

After the withdrawal of Jansen Korea, AstraZeneca Korea was the second largest after Novartis Korea.

 

The KDPU was launched in 2012 by multinational companies under the Federation of Korean chemical Workers’ Unions.

 

At the time, 8 companies including ▲Novartis Korea ▲Takeda Korea▲Sanofi-Pasteur ▲AstraZeneca Korea ▲Wyeth Korea ▲Zuellig Pharma Korea ▲ Bristol-Myers Squibb Korea and ▲Janssen Korea participated as founding members.

 

Since then, ▲Baxter Korea ▲Merck KGaA ▲Ferring Pharmaceuticals, Korea ▲Allergan Korea ▲Fresenius Kabi Korea ▲Fresenius Medical Care ▲Abbvie Korea ▲Astellas ▲MDS Korea ▲Mundipharma Korea ▲Galderma Korea ▲Zuelligpharma services Korea joined as a new union branch.

 

Among domestic companies, Kolon pharma has attracted attention by joining the union.

 

Among them, Janssen Korea, Novonordisk and AstraZeneca Korea withdrew, and currently, there are 18 branches under the KDPU.